MEDICLIN AG (DE:MED)

XETRA:MED

MED

MEDICLIN

RESEARCH TOOLSreports

Want to see DE:MED full AI Analyst Report?

MEDICLIN (MED) Price & Analysis

1 Followers

MED Stock Chart & Stats

€3.60

-€0.06(-2.44%)

At close: Jan 08 4:00 PM EST

€3.60

-€0.06(-2.44%)

Day’s Range― - ―

52-Week Range€2.86 - €4.26

Previous CloseN/A

Volume500.00

Average Volume (3M)5.25K

Market Cap

€199.50M

Enterprise Value€468.92M

Total Cash (Recent Filing)€152.40M

Total Debt (Recent Filing)€369.54M

Price to Earnings (P/E)7.3

Beta0.24

Next Earnings

Jul 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.12%

Share Statistics

EPS (TTM)0.60

Shares Outstanding47,500,000

10 Day Avg. Volume4,347

30 Day Avg. Volume5,253

Financial Highlights & Ratios

PEG Ratio1.79

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€805.74M

Bulls Say, Bears Say

Bulls Say

Cash GenerationConsistent TTM operating cash flow (~€94m) and positive free cash flow (~€49m) provide durable internal funding. This cash generation supports necessary capex for clinic upkeep, funds distributions, and gives management runway to reduce leverage or invest in service expansion over the coming months.

Improving Revenue & ProfitabilityA 26% TTM revenue increase alongside positive EBIT and net margins signals a structural recovery in utilization and service mix. If sustained, higher volumes and modest margin expansion can translate into durable operating leverage across the clinic network and more predictable cash flows.

Defensive, Diversified Care ModelMEDICLIN's portfolio of inpatient, rehab and outpatient services yields recurring, reimbursement-backed revenue streams tied to healthcare demand. The diversified service mix and essential nature of care create structural resilience and steady baseline demand over multi-month horizons.

Bears Say

Elevated LeverageA debt-to-equity ratio near 1.46x leaves the company materially leveraged. Elevated leverage constrains financial flexibility, raises refinancing risk if conditions tighten, and means cash generation must be prioritized for interest and principal, slowing strategic investment or faster deleveraging.

Margin Volatility & Thin ProfitabilityHistorical swings (including a 2023 loss and variable gross margins) indicate earnings are sensitive to utilization and cost dynamics. Thin net and EBIT margins increase downside risk from reimbursement pressure or cost inflation and make earnings less predictable over time.

Weak FCF ConversionNegative FCF growth and FCF equal to roughly half of reported net income imply conversion weakness. Slower cash conversion limits the speed at which the company can pay down debt, invest in new capacity, or absorb shocks without tapping external funding.

MED FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest stock price was €2.86 and its highest was €4.26 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €199.50M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is Jul 30, 2026 which is in 49 days.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on May 04, 2026. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 1.12%. See more information on MEDICLIN AG dividends here

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.725%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in DE:MED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

10.71%

Trailing 12-Months

Asset Growth

-6.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MEDICLIN AG

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.